Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

A model for hepatitis B virus-associated chronic liver disease has been made using cloned ... severe combined immunodeficiency (SCID) mouse that consistently supports HBV gene expression and ...

Liver issues, including a buildup of fat in the liver, occur before the onset of neuromuscular disease, per a study in a mouse model of SMA.

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

VANCOUVER, Washington, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential ...

Announcing a new publication for Acta Materia Medica journal. Estrogens have been reported to cause dysfunction in biliary transport systems, thereby inducing cholestasis. Multidrug ...

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study. Blocking ...

A common antihistamine may offer hope for patients with a rare genetic disease that can ... independent toxin-induced EPP mouse model. They also showed in EPP liver cell culture models that ...

Announcing a new publication for Acta Materia Medica journal. Estrogens have been reported to cause dysfunction in biliary transport systems, thereby inducing cholestasis. Multidrug ...

EPP results from reduced ferrochelatase activity, causing PP-IX accumulation in the liver ... disease. In the present study, the methods involved high-throughput drug screening using a zebrafish ...